• Support MPN
Logo Logo
  • Investigations
  • Opinion & Analysis
  • Cartoons
  • Podcasts
  • Videos
  • Language
    • 中文
    • русский
    • Español
  • Support MPN

India Blocks Colgate Patents For Commonly Used Spices

Follow Us

  • Rokfin
  • Telegram
  • Rumble
  • Odysee
  • Facebook
  • Twitter
  • Instagram
  • YouTube
Protest urge the Indian government to refrain from signing the Trans Pacific Partnership agreement, in New Delhi, India, they are concerned that the agreement will impose severe restrictions on the Indian generic drugs manufacturers and will raise the price of life saving drugs severely, affecting thousands across the globe who can only barely afford the Indian made generic drugs. Placard reads "Patent and greed leads to death."

Protest urge the Indian government to refrain from signing the Trans Pacific Partnership agreement, in New Delhi, India,

India has successfully blocked two patent claims of US consumer goods major Colgate-Palmolive, which wanted intellectual property right (IPR) cover on two oral compositions made from Indian spices and other herbs.

One patent battle took almost seven years, after the New York-based company filed a claim at the European Patent Register on September 29, 2008, for a composition containing botanical extracts from three herbs, including cinnamon, a common kitchen spice across India, known here as “dalchini”.

India opposed the claim using the traditional knowledge digital library (TKDL) database, created in the last decade to fight biopiracy.

The database, maintained by the Council of Scientific and Industrial Research (CSIR), submitted its plea in May 2011, and the European patent office ruled in India’s favour last month.

Two years after filing the first patent claim, Colgate-Palmolive moved another application in 2010 before the European patent office, seeking protection for another oral composition containing nutmeg, ginger, “Bakul” tree, camphor, cinnamon, turmeric, Indian banyan, black pepper, long pepper, Neem and clove. The solution is for treating oral cavity diseases.

This, too, was challenged in June 2014 by TKDL, which showed to the patent examiner there was no novelty in the Colgate claims as ancient Indian texts mention use of extracts from these plants for the same disorders. The claim was rejected this March.

 

Read more:
India blocks Colgate patents for spices

Comments
Deccan Herald
July 20th, 2015

What’s Hot

Cognitive Warfare: Israel Targets Journalists Who Threaten Its Reality-Creation Tactics

British “Watchdog” Journalists Unmasked as Lap Dogs for the Security State

The Federal Bureau of Tweets: Twitter Is Hiring an Alarming Number of FBI Agents

“Top Gun: Maverick” is Military Propaganda. Official Documents Prove It

Elon Musk, Proofpoint, and the Tentacles of the Surveillance State, with Alan MacLeod

 
  • Contact Us
  • Archives
  • About Us
  • Privacy Policy
© 2022 MintPress News